US and China Agree to Temporary 90-Day Tariff Reduction, Slash Rates by Over 100%

2 minutes

On 12 May 2025, the United States and China agreed to temporarily reduce tariffs, easing bilateral trade tensions during a 90-day period. In a Joint Statement, both countries outlined the terms of the agreement following negotiations held in Geneva, Switzerland.

the white house

Under the agreement, beginning 14 May 2025, both countries will reduce their respective tariff rates on each other's goods by 115% for 90 days. As a result, the overall tariff rate of 145% will fall from 145% to 30%, while China's rate on US goods will decrease from 125% to 10%.

More specifically, the United States will suspend 24% of additional tariffs imposed on 2 April 2025, and eliminate tariffs imposed on 8 and 9 April 2025. China will similarly suspend 24% of tariffs introduced under Announcement No. 4 (4 April 2025), remove additional measures from Announcements No. 5 and No. 6, remove retaliatory tariffs and suspend non-tariff countermeasures adopted since 2 April 2025.

Despite the reductions, both countries will retain a 10% baseline tariff during the 90-day period, with the United States maintaining pre-April 2025 tariffs including section 301 and 232 tariffs, and duties imposed in response to the fentanyl national emergency.

In a Fact Sheet, the White House described the deal as a "historic trade win" for the United States. The development also marks the first joint statement of the United States and China on trade in many years.

As of date of publication, China has not issued any official document confirming the joint statement.

Note: The trade deal comes after a series of aggressive US tariff actions introduced under President Trump's trade policy agenda, aimed at protecting domestic industries from what he characterized as unfair international competition. 

Visit our Tax Research Platform for prior coverage on US tariffs.

Related

Tax News
Other Taxes, Specific Sectors, Tariffs

United States to Remove Tariffs on UK Pharmaceuticals, Suspend Section 301 Actions under New Trade Deal

The United States will exempt UK-origin pharmaceuticals, pharmaceutical ingredients, and medical technology from section 232 tariffs and suspend future section 301 actions targeting UK pharmaceutical pricing practices for the duration of President Trump's term, under a new bilateral agreement in principal announced on 1 December 2025.The Office of the United States Trade Representative (USTR), together with the Departments of Commerce and Health and Human Services, confirmed in a 1 December 2025 news release that the tariff exemptions form part of a broader US–UK Economic Prosperity Deal (EPD). The agreement aims to address long-standing imbalances in pharmaceutical trade and foster innovation and investment in both countries.
2 minutes

Mexico Adopts 2026 Economic Package Containing Various Tax Measures

Mexico has adopted the Economic Package for fiscal year 2026 which was submitted earlier this year. The final version includes additional measures beyond those proposed in the initial draft. For previous reporting, see Economic Package for 2026: Executive Branch Proposes Amendments to Tax Incentives, New Obligations for Digital Platforms (12 September 2025).The main changes concern measures related to excise taxes, real-time access to digital platforms information, and tax incentives for the insurance sector. They are as follows:
2 minutes
Tax News
Tariffs, Tax Treaties

US Begins Investigation Into China's Compliance With Phase One Trade Agreement

The Office of the US Trade Representative (USTR) has begun an investigation into China's compliance with the Phase One economic and trade agreement. The USTR began the investigation on 24 October 2025, after finding an "apparent failure to comply" with the terms of the agreement.
2 minutes